Charles River Laboratories
CRL
Charles River Laboratories (CRL) - Net assets
Net assets on the balance sheet as of December 2023 : $3.65 B
According to Charles River Laboratories
's latest financial reports the company has $3.65 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Charles River Laboratories - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $3.65 B | 21.02% |
| 2022-12-31 | $3.02 B | 16.65% |
| 2021-12-31 | $2.59 B | 20.91% |
| 2020-12-31 | $2.14 B | 28.63% |
| 2019-12-31 | $1.66 B | 24.52% |
| 2018-12-31 | $1.33 B | 25.78% |
| 2017-12-31 | $1.06 B | 24.62% |
| 2016-12-31 | $0.85 B | 11.52% |
| 2015-12-31 | $0.76 B | 8.69% |
| 2014-12-31 | $0.70 B | 5.97% |
| 2013-12-31 | $0.66 B | 10.19% |
| 2012-12-31 | $0.60 B | 14.38% |
| 2011-12-31 | $0.52 B | -23.43% |
| 2010-12-31 | $0.68 B | -49.87% |
| 2009-12-31 | $1.37 B | 14.54% |
| 2008-12-31 | $1.19 B | -35.65% |
| 2007-12-31 | $1.86 B | 16.18% |
| 2006-12-31 | $1.60 B | -12.65% |
| 2005-12-31 | $1.83 B | 23.91% |
| 2004-12-31 | $1.48 B | 212.19% |
| 2003-12-31 | $0.47 B | 26.3% |
| 2002-12-31 | $0.37 B | 24.28% |
| 2001-12-31 | $0.30 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $46.84 B | 1,180.19% | 🇺🇸 USA |
 SCYNEXIS SCYX | $91.99 M | -97.49% | 🇺🇸 USA |
 Repligen
RGEN | $1.97 B | -46.13% | 🇺🇸 USA |